Welcome to Omnimabs!
TEL: 02154156726 Info: info@Omnimabs.com CN
SNF1LK Antibody (C-term)
Catalog Number:OM221609
OM221609
Discount Price
OM221609-100ul
1~2 Week
100ul
OM221609-50ul
50ul
OM221609-20ul
20ul
1~2 Week
Product Profile
Product Name SNF1LK Antibody (C-term)
Antibody Type Primary Antibodies
Antigen Alias SIK1; SIK; SNF1LK; Serine/threonine-protein kinase SIK1; Salt-inducible kinase 1; Serine/threonine-protein kinase SNF1-like kinase 1
Key Feature
Clonality Polyclonal
Isotype Ig
Host Species Rabbit
Tested Applications IHCWB
IHC:1:50~100 WB
Species Reactivity Human
Concentration 1mg/ml
Target Information
Gene Synonyms SIK
SNF1LK
Alternative Names SIK1
SIK
SNF1LK
Serine/threonine-protein kinase SIK1
Salt-inducible kinase 1
Serine/threonine-protein kinase SNF1-like kinase 1
Molecular Weight(MW) 84902 Da
Function Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1
Tissue Specificity This SNF1LK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 578~607 amino acids from the C-terminal region of human SNF1LK.
Cellular Localization Cytoplasm. Nucleus. Note=Following ACTH (adrenocorticotropic hormone) treatment and subsequent phosphorylation by PKA, translocates to the cytoplasm, where it binds to YWHAZ
Database Links
Entrez Gene 150094
Application

Application

Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Application

SNF1LK Antibody (C-term) western blot analysis in SK-BR-3 cell line lysates (35ug/lane).This demonstrates the SNF1LK antibody detected the SNF1LK protein (arrow).

Application

SNF1LK Antibody (C-term) western blot analysis in mouse brain tissue lysates (35ug/lane).This demonstrates the SNF1LK antibody detected the SNF1LK protein (arrow).
Application Notes IHC:1:50~100 WB
Additional Information
Form Liquid
Storage Instructions For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
validation
question title
question detaiil
Verification code